Anixa Biosciences Inc.

NASDAQ: ANIX · Real-Time Price · USD
3.22
-0.16 (-4.73%)
At close: Jun 27, 2025, 3:59 PM
3.15
-2.05%
After-hours: Jun 27, 2025, 05:47 PM EDT
-4.73%
Bid 3.1
Market Cap 103.59M
Revenue (ttm) n/a
Net Income (ttm) -12.13M
EPS (ttm) -0.38
PE Ratio (ttm) -8.46
Forward PE -9.39
Analyst Buy
Ask 3.2
Volume 89,496
Avg. Volume (20D) 112,667
Open 3.40
Previous Close 3.38
Day's Range 3.19 - 3.40
52-Week Range 2.07 - 4.20
Beta 0.33

About ANIX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANIX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ANIX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
2 weeks ago
+23.19%
Anixa Biosciences shares are trading higher after ... Unlock content with Pro Subscription
3 weeks ago
+12.45%
Anixa Biosciences shares are trading higher after the company announced it completed enrollment for its Phase 1 breast cancer vaccine clinical trial.